[1]
V. V. Zlatkina, A. O. Nesen, and N. V. Demikhova, “Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 2: Metabolomic aspects of nephroprotection”, Ukr. J. Nephrol. Dial., no. 1(89), pp. 94-100, Mar. 2026.